+7 (495) 925-30-74
Home >> News

News

Articles on page:
The first innovative Russian drug in the 21 century was registered in Russia for treatment of HIV infection
Moscow, June 24, 2017 — ELPIDA® (elsulfavirin), a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) ...
25.07.2017
read more
NeuroNet, AvtoNet and NP GLONASS have sign a tripartite agreement on cooperation in the framework of the NTI
At the St. Petersburg International Economic Forum held at the site of ASI Boiling Point, Andrey Ivashchenko, the ...
02.06.2017
read more
The Chairman of the Board of Directors of ChemRar Group Andrey Ivashchenko participates in the panel of judges of the GenerationS final
On April 25, 2017 the Moscow Stadium Live concert hall hosted the final of GenerationS — the largest startup ...
04.05.2017
read more
The leader of the NeuroNet WG Andrey Ivashchenko has participated in the Skolkovo Robotics panel discussion
On April 21, 2017 Skolkovo held the Fifth Skolkovo Robotics International Conference 2017, organized by the Skolkovo ...
28.04.2017
read more
ChemRar Group is announcing a successful completion of a safety evaluation of a new-generation drug for the treatment of all influenza virus forms with a broad spectrum of action
  ChemRar Group (ChemRar) has announced a successful completion of a safety and tolerability trial of a ...
25.04.2017
read more
IPHARMA reaches new heights
IPHARMA has maintained a leading position among contract research organizations in the volume of local drugs studies ...
21.04.2017
read more
Ajax Call Form
Loading...
Close